Physician profile
Stacy Warner
NPI 1891380457
$441.37
in general payments reported to CMS, 2019-2025
12 companies · $182 in 2025
The $182 reported for 2025 was more than what a typical Obstetrics & Gynecology (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $197 · 2024: $62.48 · 2025: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $441.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $441.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $102.43 | 2023 | |
| Coopersurgical, INC. | $43.35 | 2023-2024 | Paragard T 380a, Paragard T 380a |
| Hologic Sales and Service, LLC | $41.24 | 2023-2025 | Novasure, Aptima |
| Millicent US INC | $41.12 | 2025 | Femlyv |
| Shield Therapeutics INC | $40.86 | 2024-2025 | |
| Exact Sciences Corporation | $36.47 | 2023-2024 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $36.35 | 2023-2025 | Myfembree |
| Organon LLC | $24.54 | 2025 | Nexplanon |
| Exeltis, USA INC. | $20.74 | 2025 | Slynd |
| Biogen, INC. | $20.21 | 2025 | Zurzuvae |
| Pfizer INC. | $18.79 | 2023 | |
| Astellas Pharma US INC | $15.27 | 2025 | Veozah |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacy Warner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.